- Home
- HTLD vs AVTX Comparison
HTLD vs AVTX Comparison
Compare HTLD & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HTLD | AVTX |
|---|---|---|
| Founded | 1978 | 2011 |
| Country | United States | United States |
| Employees | 3630 | N/A |
| Industry | Trucking Freight/Courier Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 860.7M | 710.1M |
| IPO Year | 1995 | 2015 |
Fundamental Metrics
Financial Performance| Metric | HTLD | AVTX |
|---|---|---|
| Price | $10.91 | $11.34 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 14 |
| Target Price | $13.20 | ★ $44.08 |
| AVG Volume (30 Days) | 639.2K | ★ 983.9K |
| Earning Date | 10-30-2026 | 11-05-2026 |
| Dividend Yield | ★ 0.72% | N/A |
| EPS Growth | N/A | ★ 72.07 |
| EPS | ★ 0.07 | N/A |
| Revenue | ★ $805,709,000.00 | $27,813,137.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $8.43 | N/A |
| P/E Ratio | $158.86 | ★ N/A |
| Revenue Growth | N/A | ★ 2312.27 |
| 52 Week Low | $7.00 | $11.58 |
| 52 Week High | $16.64 | $24.27 |
Technical Indicators
Market Signals| Indicator | HTLD | AVTX |
|---|---|---|
| Relative Strength Index (RSI) | 35.35 | 21.56 |
| Support Level | $10.67 | N/A |
| Resistance Level | $10.91 | $20.54 |
| Average True Range (ATR) | 0.34 | 0.78 |
| MACD | -0.02 | -0.19 |
| Stochastic Oscillator | 15.41 | 4.52 |
Price Performance
Historical ComparisonAbout HTLD Heartland Express Inc.
Heartland Express Inc, along with its subsidiaries, operates as a short, medium, and long-haul truckload carrier and transportation services provider. It mainly provides nationwide asset-based dry van truckload service for shippers across the United States, along with cross-border freight and other transportation services offered through third-party partnerships in Mexico. The group operates under the brand names of Heartland Express, Millis Transfer, Smith Transport, and CFI (for services within Mexico).
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.